Search Results

You searched for : Immixbio

	ImmixBio announces FDA Orphan drug designation for IMX-110 for the treatment of Soft Tissue Sarcoma Latest pharma news update... Oct 04
	ImmixBio and BeiGene to evaluate combination of IMX-110 and Tislelizumab in solid tumors Latest Pharma News Update... Aug 31
2 Matching result(s) found!

-Advertisements-

Trending Now
	Actor-Director Sathish Kaushik Died of a Heart Attack at the Age of 66March 09, 2023
	Soleus Push-Ups: A Laziest Exercise to Lower Blood Sugar LevelsMarch 09, 2023
	World Kidney Day 2023: Be Aware of Kidney DiseasesMarch 09, 2023
	Sushmita Sen reveals about suffering from a severe heart attack recently and Addison's disease in 2014March 06, 2023
	A significant increase in influenza A H3N2 patients that are accompanied by severe coughing and feverMarch 06, 2023
	Is AIDS or HIV curable in Ayurveda?March 03, 2023
	Artificial Sweetener Erythritol Raises the Possibility of Heart Attack.March 01, 2023
	Difference between HIV and AIDS - When to give antiretroviral therapy?March 01, 2023
	Zero Discrimination Day: Let's Raise the Voice Against DiscriminationMarch 01, 2023
	International Women’s Day 2023 – Embrace EquityFebruary 28, 2023
	Brain Tumors - Types, Symptoms and Risk FactorsFebruary 28, 2023
	World Rare Disease Day: End Stigma Against Rare Diseases.February 28, 2023
	National Science Day 2023 - Global Science for Global WellbeingFebruary 28, 2023
	Eating disorders - Types and their complicationsFebruary 27, 2023
	The condition that took away the life of Malayalam filmmaker, Joseph ManuFebruary 27, 2023
	World NGO Day 2023 - We make a living by what we get, but we make a life by what we giveFebruary 27, 2023
	Functions and Problems of SerotoninFebruary 25, 2023
	Arthritis management – Tips to manage arthritis effectivelyFebruary 25, 2023
	Apple has undertaken a project of no-prick blood sugar monitoring feature for its watch.February 24, 2023
	Bird flu – Jharkhand on alert, know its prevention and symptoms in humansFebruary 24, 2023

Search Results

ImmixBio announces FDA Orphan drug designation for IMX-110 for the treatment of Soft Tissue Sarcoma

ImmixBio and BeiGene to evaluate combination of IMX-110 and Tislelizumab in solid tumors

Trending Now